Showing results (101-110 of 220) with videos related to
Sort By:
Pageof 22
Kidney International|December 9, 2016
Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathyJan Wysocki, Minghao Ye, Ahmed M Khattab, et al.The Journal of Clinical Investigation|May 22, 2002
Anabolic effects of a G protein-coupled receptor kinase inhibitor expressed in osteoblastsRobert F Spurney, Patrick J Flannery, Sanford C Garner, et al.Bone Research|July 29, 2016
The hypoxia-inducible factor-1α activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalaciaQian Zhang, Michele Doucet, Ryan E Tomlinson, et al.The Journal of Clinical Endocrinology and Metabolism|October 15, 2010
Elevated FGF23 levels are associated with impaired calcium-mediated suppression of PTH in ESRDJames B Wetmore, Peter W Santos, Jonathan D Mahnken, et al.Current Opinion in Nephrology and Hypertension|May 21, 2019
Bone and heart health in chronic kidney disease: role of dentin matrix protein 1Aline MartinEndocrinology|April 23, 2005
Leptin modulates both resorption and formation while preventing disuse-induced bone loss in tail-suspended female ratsAline Martin, Raphaël de Vittoris, Valentin David, et al.Mutagenesis|June 12, 2009
RUNX2 mutations in Chinese patients with cleidocranial dysplasiaYalin Li, Wei Pan, Wanfeng Xu, et al.Journal of Chemical Information and Modeling|July 22, 2022
Identification of Small-Molecule Inhibitors of Fibroblast Growth Factor 23 Signaling via In Silico Hot Spot Prediction and Molecular Docking to α-KlothoShih-Hsien Liu, Zhousheng Xiao, Sambit K Mishra, et al.Scientific Reports|July 9, 2020
Humanized GPRC6AKGKY is a gain-of-function polymorphism in miceMin Pi, Fuyi Xu, Ruisong Ye, et al.Pageof 22